科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/08/15 | 3,599 | 3,615 | 3,573 | 3,581 | -18 | -0.5% | 85,800 |
| 2023/08/14 | 3,601 | 3,633 | 3,582 | 3,599 | -6 | -0.2% | 142,000 |
| 2023/08/10 | 3,593 | 3,605 | 3,566 | 3,605 | +16 | +0.4% | 115,400 |
| 2023/08/09 | 3,551 | 3,590 | 3,531 | 3,589 | +44 | +1.2% | 132,500 |
| 2023/08/08 | 3,538 | 3,560 | 3,528 | 3,545 | +24 | +0.7% | 178,400 |
| 2023/08/07 | 3,548 | 3,569 | 3,496 | 3,521 | -21 | -0.6% | 191,700 |
| 2023/08/04 | 3,526 | 3,545 | 3,501 | 3,542 | +16 | +0.5% | 164,300 |
| 2023/08/03 | 3,519 | 3,552 | 3,502 | 3,526 | -9 | -0.3% | 199,800 |
| 2023/08/02 | 3,531 | 3,562 | 3,526 | 3,535 | -30 | -0.8% | 131,300 |
| 2023/08/01 | 3,538 | 3,567 | 3,529 | 3,565 | +24 | +0.7% | 168,500 |
| 2023/07/31 | 3,539 | 3,543 | 3,509 | 3,541 | +43 | +1.2% | 288,200 |
| 2023/07/28 | 3,465 | 3,505 | 3,454 | 3,498 | +3 | +0.1% | 186,800 |
| 2023/07/27 | 3,483 | 3,495 | 3,474 | 3,495 | +2 | +0.1% | 169,600 |
| 2023/07/26 | 3,492 | 3,499 | 3,479 | 3,493 | -9 | -0.3% | 141,400 |
| 2023/07/25 | 3,515 | 3,516 | 3,491 | 3,502 | -20 | -0.6% | 103,600 |
| 2023/07/24 | 3,538 | 3,546 | 3,517 | 3,522 | +21 | +0.6% | 77,800 |
| 2023/07/21 | 3,488 | 3,509 | 3,483 | 3,501 | +13 | +0.4% | 87,000 |
| 2023/07/20 | 3,531 | 3,533 | 3,486 | 3,488 | -45 | -1.3% | 149,100 |
| 2023/07/19 | 3,522 | 3,533 | 3,498 | 3,533 | +30 | +0.9% | 108,800 |
| 2023/07/18 | 3,503 | 3,532 | 3,490 | 3,503 | +7 | +0.2% | 78,500 |
| 2023/07/14 | 3,488 | 3,498 | 3,474 | 3,496 | +10 | +0.3% | 133,700 |
| 2023/07/13 | 3,500 | 3,511 | 3,482 | 3,486 | -14 | -0.4% | 103,300 |
| 2023/07/12 | 3,499 | 3,514 | 3,481 | 3,500 | -1 | ±0% | 120,100 |
| 2023/07/11 | 3,529 | 3,536 | 3,491 | 3,501 | -31 | -0.9% | 185,300 |
| 2023/07/10 | 3,535 | 3,551 | 3,519 | 3,532 | -13 | -0.4% | 126,700 |
| 2023/07/07 | 3,552 | 3,573 | 3,537 | 3,545 | -23 | -0.6% | 85,000 |
| 2023/07/06 | 3,573 | 3,602 | 3,560 | 3,568 | -20 | -0.6% | 121,100 |
| 2023/07/05 | 3,574 | 3,600 | 3,562 | 3,588 | +26 | +0.7% | 96,300 |
| 2023/07/04 | 3,600 | 3,608 | 3,500 | 3,562 | -60 | -1.7% | 248,700 |
| 2023/07/03 | 3,620 | 3,649 | 3,610 | 3,622 | +20 | +0.6% | 83,100 |
| 2023/06/30 | 3,630 | 3,639 | 3,596 | 3,602 | -37 | -1% | 114,100 |
| 2023/06/29 | 3,677 | 3,677 | 3,627 | 3,639 | -39 | -1.1% | 69,500 |
| 2023/06/28 | 3,616 | 3,678 | 3,616 | 3,678 | +49 | +1.4% | 90,500 |
| 2023/06/27 | 3,646 | 3,646 | 3,610 | 3,629 | -17 | -0.5% | 78,800 |
| 2023/06/26 | 3,657 | 3,667 | 3,611 | 3,646 | -7 | -0.2% | 42,900 |
| 2023/06/23 | 3,670 | 3,673 | 3,635 | 3,653 | -18 | -0.5% | 64,500 |
| 2023/06/22 | 3,673 | 3,695 | 3,666 | 3,671 | +3 | +0.1% | 63,400 |
| 2023/06/21 | 3,667 | 3,700 | 3,662 | 3,668 | -11 | -0.3% | 96,200 |
| 2023/06/20 | 3,674 | 3,683 | 3,651 | 3,679 | -15 | -0.4% | 84,200 |
| 2023/06/19 | 3,683 | 3,704 | 3,672 | 3,694 | +13 | +0.4% | 70,800 |
| 2023/06/16 | 3,602 | 3,682 | 3,601 | 3,681 | +80 | +2.2% | 249,000 |
| 2023/06/15 | 3,615 | 3,618 | 3,601 | 3,601 | -19 | -0.5% | 76,400 |
| 2023/06/14 | 3,667 | 3,667 | 3,616 | 3,620 | -24 | -0.7% | 78,700 |
| 2023/06/13 | 3,676 | 3,676 | 3,635 | 3,644 | -28 | -0.8% | 80,300 |
| 2023/06/12 | 3,691 | 3,715 | 3,662 | 3,672 | +3 | +0.1% | 92,800 |
| 2023/06/09 | 3,679 | 3,687 | 3,655 | 3,669 | +50 | +1.4% | 168,000 |
| 2023/06/08 | 3,633 | 3,653 | 3,594 | 3,619 | -13 | -0.4% | 91,200 |
| 2023/06/07 | 3,660 | 3,686 | 3,628 | 3,632 | -18 | -0.5% | 101,800 |
| 2023/06/06 | 3,628 | 3,658 | 3,598 | 3,650 | +22 | +0.6% | 84,300 |
| 2023/06/05 | 3,639 | 3,671 | 3,618 | 3,628 | +43 | +1.2% | 127,300 |
451～
500
件表示中 / 3723件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 386,000円 | -6.4% | -71.8% | 4.92% | 43.11倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| ジーエヌアイ | 378,000円 | +21.7% | +999.9% | 0.00% | 15.84倍 | 5.24倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 鳥居薬 | 634,000円 | +7.1% | -35.0% | 0.00% | 52.43倍 | 1.47倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| 東和薬品 | 299,900円 | +7.9% | -3.3% | 2.67% | 8.34倍 | 0.86倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ゼリア新薬 | 203,900円 | +3.1% | -6.5% | 2.35% | 9.46倍 | 1.00倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム
